Capturing data…
Capturing data…
WED, 4 NOV · 79 ITEMS
"Hematotoxicity: clonal mutated haematopoiesis linked to CAR T cell therapy" — Nature Genetics · Science & Medicine
This is a peer-reviewed Nature Genetics study showing that — the expansion of blood stem cells carrying certain mutations — is linked to after CAR T-cell therapy. The key finding is that during the intense bone-marrow inflammation that CAR T-cell treatment triggers, these pre-existing mutated clones expand and disrupt normal blood regeneration, contributing to prolonged low blood counts after therapy. It adds to growing evidence that clonal haematopoiesis is a risk factor for delayed haematologic recovery and possibly secondary blood cancers in CAR T-cell patients.
The claim comes straight from the primary source: the Nature Genetics paper itself (doi:10.1038/s41588-026-02805-6), so the reporting sits directly on the study's own data. The causal link is the authors' interpretation from mechanistic models plus clinical association, so it is best described as strong new evidence rather than a settled population-level fact.
Genuinely new: the Nature Genetics paper has just been published in the current wave, with no recirculation year indicated.